In addition, the results derived from LN229, 091116, and 091214 cells (Supplementary Figure 2) further validated the roles of JUN, CEBPB, and HDAC3 in regulating the drug resistance phenotype of hypoxic GBM cells. The gene discussed is HDAC3; the disease is glioblastoma.